Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Bayer

Status: Completed

Conditions: Sunscreen Agents

Treatments: Drug: SPF 15 Control; Drug: BAY 987519

Study type: Interventional

Funder types: Industry

Identifiers

NCT02872233

18319

Details and patient eligibility

About

Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.

Enrollment: 6 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Male or female of an age of 18 to 70 years inclusive;
• Fitzpatrick Skin Type I, II and/or III for SPF testing;
• Good health as determined from the CRO Subject History Form (SHF);
• Signed and dated Informed Consent Form;
• Signed and dated Health Insurance Portability and Accountability Act (HIPAA) Form;
• An unambiguous minimal erythema dose (MED).

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

6 participants in 1 patient group

SPF evaluation

Experimental group

Description:

Subjects with good health as determined from the CRO Subject History Form (SHF) and Fitzpatrick Skin Type I, II and/or III were included for SPF testing.

Treatment:

Drug: BAY 987519

Drug: SPF 15 Control